Total Valuation
MindMaze Therapeutics Holding SA has a market cap or net worth of $40.16M. The enterprise value is $16.26.
Market Cap$40.16M
Enterprise Value$16.26
Share Statistics
MindMaze Therapeutics Holding SA has 181,497,670 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding181,497,670
Owned by Insiders―
Owned by Institutions<0.01%
Financial Efficiency
MindMaze Therapeutics Holding SA’s return on equity (ROE) is ― and return on invested capital (ROIC) is ―.
Return on Equity (ROE)―
Return on Assets (ROA)―
Return on Invested Capital (ROIC)―
Return on Capital Employed (ROCE)―
Revenue Per Employee―
Profits Per Employee―
Employee Count10
Asset Turnover―
Inventory Turnover―
Valuation Ratios
The current PE Ratio of MindMaze Therapeutics Holding SA is ―. MindMaze Therapeutics Holding SA’s PEG ratio is 0.04.
PE Ratio―
PS Ratio6.27
PB Ratio1.44
Price to Fair Value―
Price to FCF-17.10
Price to Operating Cash Flow―
PEG Ratio0.04
Income Statement
In the last 12 months, MindMaze Therapeutics Holding SA had revenue of ― and earned ― in profits. Earnings per share was ―.
Revenue―
Gross Profit―
Operating Income―
Pretax Income―
Net Income―
EBITDA―
Earnings Per Share (EPS)―
Cash Flow
In the last 12 months, operating cash flow was ― and capital expenditures ―, giving a free cash flow of ― billion.
Operating Cash Flow―
Free Cash Flow―
Free Cash Flow per Share―
Dividends & Yields
MindMaze Therapeutics Holding SA pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.34
52-Week Price Change-93.54%
50-Day Moving Average0.26
200-Day Moving Average1.12
Relative Strength Index (RSI)43.94
Average Volume (3m)3.53K
Important Dates
MindMaze Therapeutics Holding SA upcoming earnings date is Aug 27, 2026, Before Open (Confirmed).
Last Earnings DateApr 9, 2026
Next Earnings DateAug 27, 2026
Ex-Dividend Date―
Financial Position
MindMaze Therapeutics Holding SA as a current ratio of ―, with Debt / Equity ratio of ―
Current Ratio―
Quick Ratio―
Debt to Market Cap―
Net Debt to EBITDA―
Interest Coverage Ratio―
Taxes
In the past 12 months, MindMaze Therapeutics Holding SA has paid ― in taxes.
Income Tax―
Effective Tax Rate―
Enterprise Valuation
MindMaze Therapeutics Holding SA EV to EBITDA ratio is ―, with an EV/FCF ratio of ―.
EV to Sales―
EV to EBITDA―
EV to Free Cash Flow―
EV to Operating Cash Flow―
Balance Sheet
MindMaze Therapeutics Holding SA has ― in cash and marketable securities with $1.90M in debt, giving a net cash position of ― billion.
Cash & Marketable Securities―
Total Debt$1.90M
Net Cash―
Net Cash Per Share―
Tangible Book Value Per Share―
Margins
Gross margin is ―, with operating margin of ―, and net profit margin of ―.
Gross Margin―
Operating Margin―
Pretax Margin―
Net Profit Margin―
EBITDA Margin―
EBIT Margin―
Analyst Forecast
The average price target for MindMaze Therapeutics Holding SA is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target―
Price Target Upside―
Analyst Consensus―
Analyst Count0
Revenue Growth Forecast―
EPS Growth Forecast―